Tiamulin is a pleuromutilin antibiotic drug that is derived semi-synthetically from a natural compound pleuromutilin initially produced by the mushroom-clitoris scaphoid. Tiamulin is primarily used as a veterinary medicine for the treatment of pneumonia, prevention of dysentery, and mycoplasma infections in pigs and poultry. It acts by inhibiting protein synthesis at the ribosomal level and is present in powder and injectable formulations. Antibiotic properties of Tiamulin aid in the treatment of a wide range of diseases caused by bacteria.
MARKET DYNAMICS
The tiamulin market is driving due to the initiatives by various private and government organizations for spreading awareness for use of antibiotics in pig farms. However, tiamulin injection can cause pain in the animals and long-term treatment with Tiamulin results in its resistance in bacteria that hamper the market growth during the forecast period. Moreover, increasing demand for pork and poultry meat along with increase in pig farming and poultry is expected to propel demand for antibiotic drug tiamulin and fuel global tiamulin market growth.
MARKET SCOPE
The "Tiamulin Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of tiamulin market with detailed market segmentation by dosage form, target form and distribution channel. The tiamulin market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in tiamulin market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The tiamulin market is segmented on the basis of dosage form, target form and distribution channel. Based on dosage form, the market is segmented as powder and injectable. On the basis of target animal, the market is categorized as pigs, poultry, and others. On the basis of distribution channel, the market is categorized as veterinary hospital, retail pharmacies, and online pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the tiamulin market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The tiamulin market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting tiamulin market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the tiamulin market in these regions.
MARKET PLAYERS
The report covers key developments in the tiamulin market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from tiamulin market are anticipated to have lucrative growth opportunities in the future with the rising demand for tiamulin in the global market. Below mentioned is the list of few companies engaged in the tiamulin market.
The report also includes the profiles of key players in tiamulin market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Elanco Inc.
- Hengbang Biology (China)
- Hester Biosciences Limited
- Huvepharma AD
- Jiangsu SEL Biochem
- Ningxia Tairui (China)
- Shandong Shengli Co Ltd
- Zhejiang Shenghua Biok Biology (China)
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.